148 related articles for article (PubMed ID: 36230567)
1. Concomitant Use of Sulforaphane Enhances Antitumor Efficacy of Sunitinib in Renal Cell Carcinoma In Vitro.
Tsaur I; Thomas A; Taskiran E; Rutz J; Chun FK; Haferkamp A; Juengel E; Blaheta RA
Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230567
[TBL] [Abstract][Full Text] [Related]
2. Sulforaphane as an adjunctive to everolimus counteracts everolimus resistance in renal cancer cell lines.
Juengel E; Euler S; Maxeiner S; Rutz J; Justin S; Roos F; Khoder W; Nelson K; Bechstein WO; Blaheta RA
Phytomedicine; 2017 Apr; 27():1-7. PubMed ID: 28314474
[TBL] [Abstract][Full Text] [Related]
3. Chronic Sulforaphane Administration Inhibits Resistance to the mTOR-Inhibitor Everolimus in Bladder Cancer Cells.
Justin S; Rutz J; Maxeiner S; Chun FK; Juengel E; Blaheta RA
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32512849
[TBL] [Abstract][Full Text] [Related]
4. Sulforaphane inhibits proliferation and invasive activity of everolimus-resistant kidney cancer cells in vitro.
Juengel E; Maxeiner S; Rutz J; Justin S; Roos F; Khoder W; Tsaur I; Nelson K; Bechstein WO; Haferkamp A; Blaheta RA
Oncotarget; 2016 Dec; 7(51):85208-85219. PubMed ID: 27863441
[TBL] [Abstract][Full Text] [Related]
5. Chronic Sulforaphane Application Does Not Induce Resistance in Renal Cell Carcinoma Cells.
Rutz J; Juengel E; Euler S; Maxeiner S; Justin S; Roos F; Chun FK; Blaheta RA
Anticancer Res; 2018 Nov; 38(11):6201-6207. PubMed ID: 30396938
[TBL] [Abstract][Full Text] [Related]
6. Sulforaphane Reduces Prostate Cancer Cell Growth and Proliferation In Vitro by Modulating the Cdk-Cyclin Axis and Expression of the CD44 Variants 4, 5, and 7.
Rutz J; Thaler S; Maxeiner S; Chun FK; Blaheta RA
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33218199
[TBL] [Abstract][Full Text] [Related]
7. p53-independent G1 cell cycle arrest of human colon carcinoma cells HT-29 by sulforaphane is associated with induction of p21CIP1 and inhibition of expression of cyclin D1.
Shen G; Xu C; Chen C; Hebbar V; Kong AN
Cancer Chemother Pharmacol; 2006 Feb; 57(3):317-27. PubMed ID: 16170570
[TBL] [Abstract][Full Text] [Related]
8. Sulforaphane-Induced Cell Mitotic Delay and Inhibited Cell Proliferation via Regulating CDK5R1 Upregulation in Breast Cancer Cell Lines.
Hung CM; Tsai TH; Lee KT; Hsu YC
Biomedicines; 2023 Mar; 11(4):. PubMed ID: 37189614
[TBL] [Abstract][Full Text] [Related]
9. Bladder Cancer Metastasis Induced by Chronic Everolimus Application Can Be Counteracted by Sulforaphane In Vitro.
Justin S; Rutz J; Maxeiner S; Chun FK; Juengel E; Blaheta RA
Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32759798
[TBL] [Abstract][Full Text] [Related]
10. Targeting cell cycle machinery as a molecular mechanism of sulforaphane in prostate cancer prevention.
Wang L; Liu D; Ahmed T; Chung FL; Conaway C; Chiao JW
Int J Oncol; 2004 Jan; 24(1):187-92. PubMed ID: 14654956
[TBL] [Abstract][Full Text] [Related]
11. Sulforaphane induces G2-M arrest and apoptosis in high metastasis cell line of salivary gland adenoid cystic carcinoma.
Chu WF; Wu DM; Liu W; Wu LJ; Li DZ; Xu DY; Wang XF
Oral Oncol; 2009 Nov; 45(11):998-1004. PubMed ID: 19589718
[TBL] [Abstract][Full Text] [Related]
12. Plant-Derived Sulforaphane Suppresses Growth and Proliferation of Drug-Sensitive and Drug-Resistant Bladder Cancer Cell Lines In Vitro.
Xie H; Rutz J; Maxeiner S; Grein T; Thomas A; Juengel E; Chun FK; Cinatl J; Haferkamp A; Tsaur I; Blaheta RA
Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230603
[TBL] [Abstract][Full Text] [Related]
13. Induction of p21 protein protects against sulforaphane-induced mitotic arrest in LNCaP human prostate cancer cell line.
Herman-Antosiewicz A; Xiao H; Lew KL; Singh SV
Mol Cancer Ther; 2007 May; 6(5):1673-81. PubMed ID: 17513615
[TBL] [Abstract][Full Text] [Related]
14. Sulforaphane, a Dietary Isothiocyanate, Induces G₂/M Arrest in Cervical Cancer Cells through CyclinB1 Downregulation and GADD45β/CDC2 Association.
Cheng YM; Tsai CC; Hsu YC
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27626412
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of sulforaphane-induced cell cycle arrest and apoptosis in human colon cancer cells.
Parnaud G; Li P; Cassar G; Rouimi P; Tulliez J; Combaret L; Gamet-Payrastre L
Nutr Cancer; 2004; 48(2):198-206. PubMed ID: 15231455
[TBL] [Abstract][Full Text] [Related]
16. Amygdalin inhibits the growth of renal cell carcinoma cells in vitro.
Juengel E; Thomas A; Rutz J; Makarevic J; Tsaur I; Nelson K; Haferkamp A; Blaheta RA
Int J Mol Med; 2016 Feb; 37(2):526-32. PubMed ID: 26709398
[TBL] [Abstract][Full Text] [Related]
17. Combining the receptor tyrosine kinase inhibitor AEE788 and the mammalian target of rapamycin (mTOR) inhibitor RAD001 strongly inhibits adhesion and growth of renal cell carcinoma cells.
Juengel E; Engler J; Natsheh I; Jones J; Mickuckyte A; Hudak L; Jonas D; Blaheta RA
BMC Cancer; 2009 May; 9():161. PubMed ID: 19473483
[TBL] [Abstract][Full Text] [Related]
18. Sulforaphane induces cell cycle arrest and apoptosis in murine osteosarcoma cells in vitro and inhibits tumor growth in vivo.
Matsui TA; Murata H; Sakabe T; Sowa Y; Horie N; Nakanishi R; Sakai T; Kubo T
Oncol Rep; 2007 Nov; 18(5):1263-8. PubMed ID: 17914583
[TBL] [Abstract][Full Text] [Related]
19. mTOR inhibitor PP242 increases antitumor activity of sulforaphane by blocking Akt/mTOR pathway in esophageal squamous cell carcinoma.
Lu Z; Zhang Y; Xu Y; Wei H; Zhao W; Wang P; Li Y; Hou G
Mol Biol Rep; 2022 Jan; 49(1):451-461. PubMed ID: 34731371
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous Targeting of Bladder Tumor Growth, Survival, and Epithelial-to-Mesenchymal Transition with a Novel Therapeutic Combination of Acetazolamide (AZ) and Sulforaphane (SFN).
Islam SS; Mokhtari RB; Akbari P; Hatina J; Yeger H; Farhat WA
Target Oncol; 2016 Apr; 11(2):209-27. PubMed ID: 26453055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
